Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples